Protara Therapeutics, Inc. — Director's Dealing 2017

Dec 18, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PROTEON THERAPEUTICS INC (PRTO)
CIK: 0001359931
Period of Report: 2017-12-15

Reporting Person: Burke Steven Keith (SVP and Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-12-15	Common Stock	P	12000	$1.88	Acquired	117535	Direct
2017-12-15	Common Stock	G	3334	—	Disposed	114201	Direct
2017-12-15	Common Stock	G	3333	—	Disposed	110868	Direct
2017-12-15	Common Stock	G	3333	—	Disposed	107535	Direct
2017-12-15	Common Stock	G	3333	—	Acquired	8333	Indirect
2017-12-15	Common Stock	G	3333	—	Acquired	11666	Indirect

Footnotes

F1: The purchase price of $1.88 is reflective of the weighted average purchase price of all transactions reported on this line. The prices for the transactions reported on this line range from $1.875 to $1.9. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F2: This transaction involved a gift of securities by the reporting person to the William Conroy Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose.

F3: This transaction involved a gift of securities by the reporting person to the Timothy Andrew Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose.

F4: This transaction involved a gift of securities by the reporting person to the Steven Edward Burke Irrevocable Trust u/a 11/15/2000, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose.